Image pharmaphorum Editor R&D Can technology help diversify clinical trials? This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. R&D Why are clinical trials struggling with diversity? In the diverse world we live in, the products we produce, the services we create and the places we work should be as equally representative. Sales & Marketing Next generation coaching Capturing an audience is a critical task. Doing that in a wind tunnel of multi-channel white noise requires a special brand of cut-through. Patients Taking patient engagement efforts beyond box-ticking Most pharma and biopharma executives agree the patient voice should be at the centre of everything they do. Load more results
R&D Can technology help diversify clinical trials? This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials.
R&D Why are clinical trials struggling with diversity? In the diverse world we live in, the products we produce, the services we create and the places we work should be as equally representative.
Sales & Marketing Next generation coaching Capturing an audience is a critical task. Doing that in a wind tunnel of multi-channel white noise requires a special brand of cut-through.
Patients Taking patient engagement efforts beyond box-ticking Most pharma and biopharma executives agree the patient voice should be at the centre of everything they do.
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.